北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学第一临床医学院  > 心血管内科  > 期刊论文
学科主题: 临床医学
题名:
Efficacy and safety of serial atorvastatin load in Chinese patients undergoing elective percutaneous coronary intervention: results of the ISCAP (Intensive Statin Therapy for Chinese Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention) randomized controlled trial
作者: Zheng, Bo1; Jiang, Jie1; Liu, Huiliang2; Zhang, Jun3; Li, Hui4; Su, Xi5; Wang, Haichang6; Song, Zhiyuan7; Han, Yaling8; Lei, Han9; Cong, Hongliang10; Zhang, Zheng11; Ma, Yitong12; Wang, Jian′ an13; Xu, Biao14; Sun, Yingxian15; Gao, Chuanyu16; Zheng, Yang17; Liu, Bin18; Huang, Dejia19; Li, Bao20; Huang, Congxin21; Yang, Tianlun22; Wan, Zheng23; Jia, Shaobin24; Chen, Dafang25; Ge, Junbo26; Huo, Yong1
关键词: Atorvastatin ; Percutaneous coronary intervention ; Periprocedural myocardial infarction
刊名: EUROPEAN HEART JOURNAL SUPPLEMENTS
发表日期: 2015-03-01
DOI: 10.1093/eurheartj/suv021
卷: 17, 期:B, 页:B47-B56
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Cardiac & Cardiovascular Systems
研究领域[WOS]: Cardiovascular System & Cardiology
关键词[WOS]: TREATMENT PLATELET REACTIVITY ; CLOPIDOGREL RESPONSIVENESS ; OUTCOMES ; GENE ; IMPLANTATION ; ASPIRIN ; EVENTS ; IMPACT
英文摘要:

Although several studies have suggested that intensive statin pretreatment could reduce the incidence of procedure-related myocardial infarction in western population, the data on the effect in Asian patients have been still limited. The aim of the study was to investigate the efficacy and safety of intensive atorvastatin load in Chinese patients undergoing elective PCI. A total of 1202 patients with stable angina or non-ST-segment elevation acute coronary syndrome (NSTE-ACS) scheduled to undergo PCI received either intensive statin treatment (80 mg atorvastatin daily x 2 days before PCI and 40 mg daily x 30 days after PCI) or usual care. The primary endpoint was incidence of major adverse cardiac events (cardiac death, myocardial infarction, or unexpected target vessel revascularization) within 30 days after PCI. Safety endpoints include the incidence of contrast induced nephropathy (CIN), ALT/AST >3 upper limit of normal (ULN), CK >5 ULN. The incidence of 30-day MACE did not significantly differ between the intensive group and control group (19.4 vs 18.3%, P = 0.63). Multivariate analysis revealed age (OR = 1.024, 95% CI 1.003-1.045, P = 0.023) and total stent length as an independent predictor of 30-day MACE (OR = 1.012, 95% CI 1.007-1.018, P < 0.0001). The incidence of CIN was comparable between intensive group and control group (4.09 vs 4.39%, P = 0.795). No significant differences were observed in other safety profile at all follow-ups between treatment groups. The ISCAP trial demonstrated that serial intensive atorvastatin therapy did not improve the clinical outcome with similar safety profile comparing with usual care among Chinese patients undergoing elective PCI.

语种: 英语
所属项目编号: 2011BAI11B07 ; 2012ZX093016-002
项目资助者: National Key Technology R&amp ; D Program in the 12th Five-year Plan of China
WOS记录号: WOS:000357873000004
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/58543
Appears in Collections:北京大学第一临床医学院_心血管内科_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Daqing Oilfield Gen Hosp, Dept Cardiol, Harbin, Peoples R China
2.Wuhan Asia Heart Hosp, Dept Cardiol, Wuhan, Hubei, Peoples R China
3.Tianjin Chest Hosp, Dept Cardiol, Tianjin, Peoples R China
4.Peking Univ, Hosp 1, Dept Cardiol, Beijing 100034, Peoples R China
5.Chinese Peoples Armed Police Forces, Gen Hosp, Dept Cardiol, Beijing, Peoples R China
6.HeBei Med Univ, Affiliated Hosp, Dept Cardiol, Cangzhou Cent Hosp, Cangzhou, Hebei, Peoples R China
7.Fourth Mil Med Univ, Xijing Hosp, Dept Cardiol, Xian 710032, Shanxi, Peoples R China
8.Third Mil Med Univ, Southwest Hosp, Dept Cardiol, Chongqing, Peoples R China
9.Gen Hosp Shenyang Mil Reg, Dept Cardiol, Shenyang, Liaoning, Peoples R China
10.Chongqing Med Univ, Affiliated Hosp 1, Dept Cardiol, Chongqing, Peoples R China
11.Lanzhou Univ, Affiliated Hosp 1, Dept Cardiol, Lanzhou 730000, Gansu, Peoples R China
12.Xinjiang Med Univ, Affiliated Hosp 1, Dept Cardiol, Urumqi, Xinjiang, Peoples R China
13.Zhejiang Univ, Affiliated Hosp 2, Dept Cardiol, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China
14.Nanjing Univ, Sch Med, Dept Cardiol, Gulou Hosp, Nanjing 210008, Jiangsu, Peoples R China
15.China Med Univ, Hosp 1, Dept Cardiol, Shenyang, Liaoning, Peoples R China
16.Henan Prov Peoples Hosp, Dept Cardiol, Zhengzhou, Henan, Peoples R China
17.Jilin Univ, Hosp 1, Dept Cardiol, Changchun 130023, Jilin, Peoples R China
18.Jilin Univ, Hosp 2, Dept Cardiol, Changchun 130023, Jilin, Peoples R China
19.Sichuan Univ, West China Hosp, Dept Cardiol, Chengdu 610064, Sichuan, Peoples R China
20.Shanxi Cardiovasc Hosp, Dept Cardiol, Taiyuan, Shanxi, Peoples R China
21.Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan 430072, Hubei, Peoples R China
22.Cent S Univ, Xiangya Hosp, Dept Cardiol, Changsha, Hunan, Peoples R China
23.Tianjin Med Univ, Gen Hosp, Dept Cardiol, Tianjin, Peoples R China
24.Ningxia Med Coll, Affiliated Hosp, Dept Cardiol, Ningxia, Yinchuan, Peoples R China
25.Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100034, Peoples R China
26.Fudan Univ, Zhongshan Hosp, Dept Cardiol, Shanghai 200433, Peoples R China

Recommended Citation:
Zheng, Bo,Jiang, Jie,Liu, Huiliang,et al. Efficacy and safety of serial atorvastatin load in Chinese patients undergoing elective percutaneous coronary intervention: results of the ISCAP (Intensive Statin Therapy for Chinese Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention) randomized controlled trial[J]. EUROPEAN HEART JOURNAL SUPPLEMENTS,2015,17(B):B47-B56.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Zheng, Bo]'s Articles
[Jiang, Jie]'s Articles
[Liu, Huiliang]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Zheng, Bo]‘s Articles
[Jiang, Jie]‘s Articles
[Liu, Huiliang]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit
所有评论 (0)
暂无评论
 
评注功能仅针对注册用户开放,请您登录
您对该条目有什么异议,请填写以下表单,管理员会尽快联系您。
内 容:
Email:  *
单位:
验证码:   刷新
您在IR的使用过程中有什么好的想法或者建议可以反馈给我们。
标 题:
 *
内 容:
Email:  *
验证码:   刷新

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace